What Innovative Pharmaceutical Research is Protected under the SPC-Regime? A Discussion of the ECJ's Decision in the Abraxis Case Journal Artikel Otto Swens, Carly van der Beek European Pharmaceutical Law Review, Jahrgang 3 (2019), Ausgabe 2, Seite 95 - 100
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics Anastasiya Kiseleva, Paul Quinn
A Case of Unforeseen Adverse Side-Effects? The Ireland/Northern Ireland Protocol and Medicines Regulation George Peretz, Xisca Borrás